Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial

Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial

OBJECTIVE: Clinical and immunological data about HIV in older adults from low and middle income countries is scarce. We aimed to describe differences between younger and older adults with HIV starting antiretroviral therapy in two low-income African countries. METHODS: SETTING: HIV clinics in Ugand...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	Parikh, S, Obuku, E, Walker, SA, Semeere, A, Auerbach, B, Hakim, J, Mayanja-Kizza, H, Mugyenyi, P, Salata, R, Kityo, C
פורמט:	Journal article
שפה:	English
יצא לאור:	Public Library of Science 2013

פריטים דומים

Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial.
מאת: Sujal M Parikh, et al.
יצא לאור: (2013-01-01)

The impact of first year adherence to antiretroviral therapy on long-term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe.
מאת: Kiwuwa-Muyingo, S, et al.
יצא לאור: (2012)

Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.
מאת: Walker, A, et al.
יצא לאור: (2012)

HIV-associated anemia after 96 weeks on therapy: determinants across age ranges in Uganda and Zimbabwe.
מאת: Jaganath, D, et al.
יצא לאור: (2014)

Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe
מאת: Lara, A, et al.
יצא לאור: (2012)

Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe.
מאת: Muyingo, S, et al.
יצא לאור: (2008)

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe.
מאת: Antonieta Medina Lara, et al.
יצא לאור: (2012-01-01)

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.
מאת: Walker, A, et al.
יצא לאור: (2010)

Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study.
מאת: Gomo, Z, et al.
יצא לאור: (2014)

Prevalence and factors associated with hypertension among people living with HIV/AIDS on antiretroviral therapy in Uganda
מאת: Gloria Lubega, et al.
יצא לאור: (2021-02-01)

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial
מאת: Kityo, C, et al.
יצא לאור: (2014)

Provision of antiretroviral therapy in a rural setting – The Nile treatment centre experience, Uganda
מאת: Obuku Anthony, et al.
יצא לאור: (2006-12-01)

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.
מאת: Mugyenyi, P, et al.
יצא לאור: (2010)

Evaluating the cost-effectiveness of combination antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Uganda
מאת: Andreas Kuznik, et al.
יצא לאור: (2012-08-01)

Antiretroviral Treatment-Associated Tuberculosis in a Prospective Cohort of HIV-Infected Patients Starting ART
מאת: William Worodria, et al.
יצא לאור: (2011-01-01)

DART and laboratory monitoring of HIV treatment Reply
מאת: Walker, A, et al.
יצא לאור: (2010)

Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe's national antiretroviral therapy programme between 2012 and 2015.
מאת: Richard Makurumidze, et al.
יצא לאור: (2020-01-01)

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial.
מאת: Cissy Kityo, et al.
יצא לאור: (2014-01-01)

Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.
מאת: Ssali, F, et al.
יצא לאור: (2006)

Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda
מאת: Sempa Joseph, et al.
יצא לאור: (2012-09-01)

The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at Joint Clinical Research Centre, Uganda
מאת: Odere Mathew, et al.
יצא לאור: (2009-07-01)

Agreement between physicians and non-physician clinicians in starting antiretroviral therapy in rural Uganda
מאת: Vasan Ashwin, et al.
יצא לאור: (2009-08-01)

Long-term antiretroviral treatment adherence in HIV-infected adolescents and adults in Uganda: a qualitative study
מאת: Inzaule, S, et al.
יצא לאור: (2016)

A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda.
מאת: Steven J Reynolds, et al.
יצא לאור: (2010-04-01)

Hypertension and associated risk factors in individuals infected with HIV on antiretroviral therapy at an urban HIV clinic in Uganda
מאת: Aggrey S Semeere, MMed MAS, et al.
יצא לאור: (2014-05-01)

Validation of World Health Organisation HIV/AIDS clinical staging in predicting initiation of antiretroviral therapy and clinical predictors of low CD4 cell count in Uganda.
מאת: Steven Baveewo, et al.
יצא לאור: (2011-01-01)

Causes and timing of mortality and morbidity among late presenters starting antiretroviral therapy in the REALITY trial
מאת: Post, F, et al.
יצא לאור: (2018)

Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy.
מאת: Reid, A, et al.
יצא לאור: (2008)

Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study.
מאת: Seth C Inzaule, et al.
יצא לאור: (2016-01-01)

The Clinical Presentation and Factors Associated with Disease Severity of Rheumatoid Arthritis in Uganda: A Cross-Sectional Study
מאת: Ochola B, et al.
יצא לאור: (2022-05-01)

Immediate start of antiretroviral, why not?
מאת: Elaine Monteiro Matsuda, et al.

Patient-mix, programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV "Treat All" in Zimbabwe.
מאת: Richard Makurumidze, et al.
יצא לאור: (2020-01-01)

First‐line antiretroviral therapy durability in a 10‐year cohort of naïve adults started on treatment in Uganda
מאת: Barbara Castelnuovo, et al.
יצא לאור: (2016-01-01)

Outcomes in a Cohort of Patients Started on Antiretroviral Treatment and Followed up for a Decade in an Urban Clinic in Uganda.
מאת: Barbara Castelnuovo, et al.
יצא לאור: (2015-01-01)

Correction: Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study.
מאת: Seth C Inzaule, et al.
יצא לאור: (2017-01-01)

Assessment of second-line antiretroviral regimens for HIV therapy in Africa
מאת: Paton, N, et al.
יצא לאור: (2014)

AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy
מאת: Johnston C, et al.
יצא לאור: (2009-06-01)

A 10-year retrospective study of lung cancer in Uganda
מאת: Naghib Bogere, et al.
יצא לאור: (2022-02-01)

Prevalence of overweight and obesity among adolescents living with HIV after dolutegravir - based antiretroviral therapy start in Kampala, Uganda
מאת: Irene Nakatudde, et al.
יצא לאור: (2024-04-01)

Uptake of community antiretroviral group delivery models for persons living with HIV in Arua district, Uganda: A parallel convergent mixed methods study.
מאת: Wani Muzeyi, et al.
יצא לאור: (2023-01-01)